Join
Live feed
·
INSIDERFilingvia Quantisnow
Zevra Therapeutics Inc. logo

Chief Medical Officer Quartel Adrian W converted options into 11,333 shares and sold $40,036 worth of shares (4,533 units at $8.83), increasing direct ownership by 233% to 9,723 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZVRA (Zevra Therapeutics Inc.) and more on Quantisnow.

Chief Medical Officer Quartel Adrian W converted options into 11,333 shares and sold $40,036 worth of shares (4,533 units at $8.83), increasing direct ownership by 233% to 9,723 units (SEC Form 4) | Quantisnow